Mark Deutsch, MD
Plastic Surgery · Atlanta, GANPI 1013991371
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,401 of the $6,931 with a category attached, or 77.9%. 27 manufacturers reported payments, led by AbbVie at 48.5% of the total. Reporting peaked in 2023 at $2,020 and has fallen 55.8% since, to $893 in 2025.
Across 222 payments — averaging $31.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Mentor Worldwide LLC$964
- Musculoskeletal Transplant Foundation Inc.$598
- BD$425
- TELA Bio, Inc.$373
- Integra Lifesciences Corporation$206
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$3505%
- Travel & lodging$1,18017%
- Food & beverage$5,40178%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 100 | $3,358 |
| Mentor Worldwide LLC | 35 | $964 |
| Musculoskeletal Transplant Foundation Inc. | 17 | $598 |
| BD | 3 | $425 |
| TELA Bio, Inc. | 18 | $373 |
| Integra Lifesciences Corporation | 10 | $206 |
| Access Pro Medical, LLC | 5 | $190 |
| Smith+Nephew | 3 | $139 |
| Baxter Healthcare | 3 | $90 |
| Davol Inc. | 3 | $79 |
| Polymedics Innovations Inc. | 1 | $68 |
| Tepha Inc | 3 | $51 |
| Stryker | 1 | $46 |
| Next Science LLC | 2 | $39 |
| Sientra, Inc. | 2 | $37 |
| KCI USA, Inc. | 2 | $37 |
| Bard Peripheral Vascular, Inc. | 2 | $36 |
| TEI Biosciences Inc | 2 | $28 |
| Galderma Laboratories, L.p. | 2 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Lemaitre Vascular, Inc. | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Acell, Inc. | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Medtronic | 1 | $12 |
| Molnlycke Health Care US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,931 in reported general payments places this provider in the 75th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 34 | $145 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $113 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 23 | $77 |
| Gabapentin | 12 | $71 |
| Methocarbamol | 17 | $30 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Atlanta
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Farzad NahaiAtlanta$129K
- Sara NeimanisAtlanta$51K
- Alan LarsenAtlanta$48K
- Foad NahaiAtlanta$29K
- Bahair GhaziAtlanta$17K
- Drew MetcalfeAtlanta$14K
- John SymbasAtlanta$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.